Trial · NCT01685684
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Screening | 0 | 0 | |
| other | Nausea | Gastrointestinal disorders | Oxycodone DETERx (Titration Phase) | 123 | 740 | |
| other | Nausea | Gastrointestinal disorders | Oxycodone DETERx (Double-blind Maintenance Phase) | 21 | 193 | |
| other | Nausea | Gastrointestinal disorders | Placebo (Double-blind Maintenance Phase) | 9 | 196 | |
| other | Headache | Nervous system disorders | Screening | 0 | 0 | |
| other | Headache | Nervous system disorders | Oxycodone DETERx (Titration Phase) | 103 | 740 | |
| other | Headache | Nervous system disorders | Oxycodone DETERx (Double-blind Maintenance Phase) | 12 | 193 | |
| other | Headache | Nervous system disorders | Placebo (Double-blind Maintenance Phase) | 23 | 196 | |
| other | Constipation | Gastrointestinal disorders | Screening | 0 | 0 | |
| other | Constipation | Gastrointestinal disorders | Oxycodone DETERx (Titration Phase) | 96 | 740 | |
| other | Constipation | Gastrointestinal disorders | Oxycodone DETERx (Double-blind Maintenance Phase) | 10 | 193 | |
| other | Constipation | Gastrointestinal disorders | Placebo (Double-blind Maintenance Phase) | 1 | 196 | |
| other | Somnolence | Nervous system disorders | Screening | 0 | 0 | |
| other | Somnolence | Nervous system disorders | Oxycodone DETERx (Titration Phase) | 65 | 740 | |
| other | Somnolence | Nervous system disorders | Oxycodone DETERx (Double-blind Maintenance Phase) | 1 | 193 | |
| other | Somnolence | Nervous system disorders | Placebo (Double-blind Maintenance Phase) | 0 | 196 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Screening | 0 | 0 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Oxycodone DETERx (Titration Phase) | 55 | 740 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Oxycodone DETERx (Double-blind Maintenance Phase) | 5 | 193 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Placebo (Double-blind Maintenance Phase) | 3 | 196 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01685684/events